
    
      This study will enroll up to 40 participants.

        1. 20 participants at Stanford injected with an FDA-approved PET tracer (e.g. amyloid, FDG,
           etc.), and

        2. 20 participants from Stanford who have been pre-injected with a radiopharmaceutical for
           a study on another PET imaging system
    
  